Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study

被引：6

作者：

Shady, Nourhan Hisham ^{[1
]}

Hayallah, Alaa M. ^{[2
,3
]}

Mohamed, Mamdouh F. A. ^{[4
]}

Ghoneim, Mohammed M. ^{[5
,6
]}

Chilingaryan, Garri ^{[7
,8
]}

Al-Sanea, Mohammad M. ^{[9
]}

Fouad, Mostafa A. ^{[10
]}

Kamel, Mohamed Salah ^{[1
,10
]}

Abdelmohsen, Usama Ramadan ^{[1
,10
]}

机构：

[1] Deraya Univ, Fac Pharm, Dept Pharmacognosy, New Minia City 61111, Egypt

[2] Assiut Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Assiut 71526, Egypt

[3] Sphinx Univ, Fac Pharm, Pharmaceut Chem Dept, New Assiut 71515, Egypt

[4] Sohag Univ, Fac Pharm, Dept Pharmaceut Chem, Sohag 82524, Egypt

[5] AlMaarefa Univ, Coll Pharm, Dept Pharm Practice, Ad Diriyah 13713, Saudi Arabia

[6] Al Azhar Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11371, Egypt

[7] NAS RA, Inst Mol Biol, Yerevan 0014, Armenia

[8] Russian Armenian Univ, Inst Biomed & Pharm, Yerevan 0051, Armenia

[9] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Aljouf 72341, Saudi Arabia

[10] Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya 61519, Egypt

来源：

MOLECULES | 2021年 / 26卷 / 12期

关键词：

COVID-19; coronavirus; molecular docking; Amphimedon sp; sponge; ANTICANCER ACTIVITY; NATURAL-PRODUCTS; INHIBITORS; DESIGN; PROTEASE;

D O I：

10.3390/molecules26123775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Since December 2019, novel coronavirus disease 2019 (COVID-19) pandemic has caused tremendous economic loss and serious health problems worldwide. In this study, we investigated 14 natural compounds isolated from Amphimedon sp. via a molecular docking study, to examine their ability to act as anti-COVID-19 agents. Moreover, the pharmacokinetic properties of the most promising compounds were studied. The docking study showed that virtually screened compounds were effective against the new coronavirus via dual inhibition of SARS-CoV-2 RdRp and the 3CL main protease. In particular, nakinadine B (1), 20-hepacosenoic acid (11) and amphimedoside C (12) were the most promising compounds, as they demonstrated good interactions with the pockets of both enzymes. Based on the analysis of the molecular docking results, compounds 1 and 12 were selected for molecular dynamics simulation studies. Our results showed Amphimedon sp. to be a rich source for anti-COVID-19 metabolites.

引用

页数：15

共 50 条

[21] Sensitive detection of SARS-CoV-2 main protease 3CLpro with an engineered ribonuclease zymogen
Wralstad, Evans C.
Raines, Ronald T.
PROTEIN SCIENCE, 2024, 33 (04)
[22] Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV-2
Guma, Samuel Desta
Zhou, Zhaoyin
Song, Kang
Yang, Feipu
Suo, Jin
Zhang, Yan
Bonku, Emmanuel Mintah
Odilov, Abdullajon
Tian, Guanghui
Xu, Zhijian
Jiang, Xiangrui
Zhang, Qiumeng
Zhu, Weiliang
Shen, Jingshan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 281
[23] Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro
Vincent, Savariar
Arokiyaraj, Selvaraj
Saravanan, Muthupandian
Dhanraj, Manoj
FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[24] In silico and in vitro assays reveal potential inhibitors against 3CLpro main protease of SARS-CoV-2
Iype, Eldhose
Jisha, Pillai U.
Kumar, Indresh
Gaastra-Nedea, Silvia V.
Subramanian, Ramachandran
Saha, Ranendra Narayan
Dutta, Mainak
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23) : 12800 - 12811
[25] Molecular Dynamics Simulation of Privileged Biflavonoids as SARS-CoV2 3CLpro Targeting Agents
Vahabzadeh, Taha
Miran, Mansour
Razzaghi-Asl, Nima
JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (05): : 569 - 582
[26] Quinoxaline derivatives as potent compounds against both 3CLpro and PLpro enzymes of SARS-CoV-2 virus: an insight from experimental and theoretical approaches
Noroozi-Shad, Nazanin
Sabet-Sarvestani, Hossein
Moghimi, Vahid
Afrough, Toktam
Haghbeen, Kamahldin
Eshghi, Hossein
NEW JOURNAL OF CHEMISTRY, 2024, 48 (33) : 14791 - 14800
[27] Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2?
Nascimento, Igor Jose dos Santos
de Moura, Ricardo Olimpio
MEDICINAL CHEMISTRY, 2023, 19 (05) : 405 - 412
[28] Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro
Ma, Ling
Li, Quanjie
Xie, Yongli
Zhao, Jianyuan
Yi, Dongrong
Guo, Saisai
Guo, Fei
Wang, Jing
Yang, Long
Cen, Shan
ANTIVIRAL RESEARCH, 2022, 207
[29] A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study
Jurica Novak
Vladimir A. Potemkin
Molecular Diversity, 2022, 26 : 2631 - 2645
[30] An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2
Yan, Fangfang
Gao, Feng
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 4868 - 4883

← 1 2 3 4 5 →